KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Shares Outstanding (Diluted Average) (2016 - 2023)

Astrana Health's Shares Outstanding (Diluted Average) history spans 9 years, with the latest figure at $46.9 million for Q3 2023.

  • For Q3 2023, Shares Outstanding (Diluted Average) rose 2.02% year-over-year to $46.9 million; the TTM value through Sep 2023 reached $46.9 million, up 2.02%, while the annual FY2020 figure was $37.4 million, 2.87% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2023 was $46.9 million at Astrana Health, up from $46.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $46.9 million in Q3 2023 and bottomed at $36.4 million in Q4 2019.
  • The 4-year median for Shares Outstanding (Diluted Average) is $37.9 million (2019), against an average of $39.8 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) dropped 3.99% in 2019 before it grew 2.87% in 2020.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $36.4 million in 2019, then increased by 2.87% to $37.4 million in 2020, then rose by 22.82% to $46.0 million in 2022, then rose by 2.02% to $46.9 million in 2023.
  • Per Business Quant, the three most recent readings for ASTH's Shares Outstanding (Diluted Average) are $46.9 million (Q3 2023), $46.0 million (Q3 2022), and $37.4 million (Q4 2020).